The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

Belgium’s Deputy Prime Minister, Frank Vandenbroucke, called the EU’s joint health technology assessment a model of European cooperation, improving medicine evaluation, reducing costs, and ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

Rising temperatures and the associated health risks are set to change mortality trends across Europe, with heat-related ...

Finally, the Critical Medicines Act should tackle dependency on other countries. Right now, 70% to 80% of Europe's ...

Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...

A positive opinion was also given for Dyrupeg (pegfilgrastim), a biosimilar medicine intended to shorten ... which has been authorized in the European Union since 2002. Pegfilgrastim yields ...

Extreme heat could kill as many as 2.3 million people in Europe unless countries get better at cutting emissions.

November 2024 recorded 22,000 fewer excess deaths in the EU than in November 2023. Malta, Romania, and Slovakia recorded negative excess mortality rates. #EuropeInMotion ...

Germany’s first foot and mouth disease outbreak in almost 40 years – and the EU’s first in more than a decade – sent ...

Some countries are starting to push back on the influx of Americans and other international students. Read more at straitstimes.com.